P
Market Data
$3.68+$0.45 (+13.93%)
PRLD · Last trade
Prev Close
$3.23
Range (28d)
$2.99 – $3.81
Recent Filings
- 8-K163.6 KBPrelude Therapeutics IncMar 12, 4:18 PM ET·0001193125-26-104204
- 10-K14.9 MBPrelude Therapeutics IncMar 10, 8:24 AM ET·0001193125-26-099428
- 8-K15.7 MBPrelude Therapeutics IncMar 10, 8:17 AM ET·0001193125-26-099424
- 8-K213.9 KBPrelude Therapeutics IncFeb 3, 9:11 AM ET·0001193125-26-034564
- 8-K14.4 MBPrelude Therapeutics IncJan 9, 7:30 AM ET·0001193125-26-008280
- 10-Q8.9 MBPrelude Therapeutics IncNov 12, 2:15 AM ET·0001193125-25-275887
- 8-K14.7 MBPrelude Therapeutics IncNov 12, 2:07 AM ET·0001193125-25-275871
- 8-K6.9 MBPrelude Therapeutics IncNov 4, 8:53 AM ET·0000929638-25-004115
- 8-K246.9 KBPrelude Therapeutics IncOct 17, 7:40 AM ET·0001193125-25-241968
- 8-K181.8 KBPrelude Therapeutics IncSep 19, 7:41 AM ET·0001193125-25-208187
Insiders
10- 667, L.P.Director, 10% Owner
- Babler MartinDirector
- Baker Bros. Advisors (GP) LLCDirector, 10% Owner
- BAKER BROS. ADVISORS LPDirector, 10% Owner
- Baker Brothers Life Sciences LPDirector, 10% Owner
- BAKER FELIXDirector, 10% Owner
- BAKER JULIANDirector, 10% Owner
- Bonita David PDirector, 10% Owner
- Brusky Sean P.Chief Business Officer
- Chardonnet LaurentChief Financial Officer
Tickers
Addresses
business
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
mailing
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
Former Names
- Prelude Therapeutics Inc.2017-10-20